Rezor-20 Tablet

About Rezor-20 Tablet

Rezor-20 is a tablet that lowers blood pressure by blocking a natural substance that tightens blood vessels. It contains olmesartan medoxomil 20 mg and is used for hypertension.

There are 29 brands of Olmesartan Medoxomil listed in Bangladesh. The lowest listed price is Belsar 10 mg Tablet at ৳ 6.00 per unit.

What is Rezor-20 Tablet?

Rezor-20 belongs to a group of medicines called angiotensin-II receptor blockers, often simply called ARBs. It works by blocking the action of angiotensin-II, a hormone that causes blood vessels to narrow. By blocking this hormone, the medicine helps blood vessels relax and widen, which lowers blood pressure. Rezor-20 is manufactured by Renata PLC. and comes as a 20 mg tablet. It is used to treat hypertension and may be prescribed alone or with other blood pressure medicines. The doctor decides the right dose and course for each person.

Uses of Rezor-20

Rezor-20 is used to treat high blood pressure (hypertension). It can be used on its own or together with other medicines that lower blood pressure. Lowering blood pressure helps reduce the risk of health problems linked to high blood pressure. Your doctor will decide if this medicine is suitable for you and how it should fit into your overall treatment plan.

How to use Rezor-20

Take Rezor-20 exactly as your doctor tells you. The doctor decides the dose, how often to take it, and how long to continue. Swallow the tablet with water. You can take it with or without food, as food does not affect how the medicine is absorbed. Do not change the dose or stop taking it without talking to your doctor first. If you miss a dose, ask your doctor or pharmacist what to do.

Side effects of Rezor-20

Like all medicines, Rezor-20 can cause side effects, but not everyone gets them. Common side effects include back pain, bronchitis, increased creatine phosphokinase, diarrhea, headache, blood in the urine, high blood sugar, high triglycerides, flu-like symptoms, sore throat, runny nose, and sinusitis. Rare side effects include chest pain, swelling of the legs or arms, and arthritis. Tell your doctor if you notice any side effect or if it bothers you.

Safety and precautions

Rezor-20 is not recommended during pregnancy, especially in the second and third trimesters, because it can harm the developing baby. If you become pregnant, contact your doctor right away. It is not known if the medicine passes into breast milk, so breastfeeding mothers should discuss the risks and benefits with their doctor. People with kidney problems, especially those with severe heart failure, may need careful monitoring. Tell your doctor about any allergies or other medicines you take. The doctor will decide if Rezor-20 is safe for you.

Frequently asked questions

Is Rezor-20 safe during pregnancy or breastfeeding?

Rezor-20 should not be used during pregnancy, especially in the later months, because it can harm the baby. If you are pregnant or planning to become pregnant, tell your doctor immediately. For breastfeeding, it is not known if the medicine passes into breast milk, so your doctor will weigh the benefits and risks before prescribing it.

What is Rezor-20 used for and what kind of medicine is it?

Rezor-20 is used to treat high blood pressure (hypertension). It belongs to a class of medicines called angiotensin-II receptor blockers (ARBs). It works by blocking a hormone that narrows blood vessels, helping them relax and lowering blood pressure. It can be used alone or with other blood pressure medicines.

How should I store Rezor-20?

Store Rezor-20 in a cool, dry place below 30°C. Protect it from light and moisture. Keep the tablets out of the reach of children. Do not use the medicine after the expiry date printed on the pack. Ask your pharmacist if you are unsure how to dispose of unused medicine.

Can I take Rezor-20 with food or other medicines?

Food does not affect how Rezor-20 is absorbed, so you can take it with or without food. However, always tell your doctor about all other medicines you are taking, including over-the-counter products and herbal remedies, because some may interact with this medicine. Your doctor will decide if any adjustments are needed.

Indications

Olmesartan Medoxomil is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Pharmacology

Angiotensin-II formed from angiotensin-I in a reaction catalyzed by angiotensin-converting enzyme (ACE), is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension. It also stimulates aldosterone secretion by the adrenal cortex. Olmesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin-II by selectively blocking the binding of angiotensin-II to the AT 1 receptor found in many tissues (e.g. vascular smooth muscle, adrenal gland). In-vitro-binding studies indicate that Olmesartan is a reversible & competitive inhibitor of AT 1 receptor. Olmesartan does not inhibit ACE (kinase-I, the enzyme that converts angiotensin-I to angiotensin-II and degrades bradykinin).

Dosage & Administration

Dosage must be individualized. The usual recommended starting dose of Olmesartan is 20 mg once daily when used as monotherapy in patients who are not volume-contracted. For patients requiring further reduction in blood pressure after 2 weeks of therapy, the dose of Olmesartan may be increased to 40 mg. Doses above 40 mg do not appear to have a greater effect. Twice-daily dosing offers no advantage over the same total dose given once daily.

No initial dosage adjustment is recommended for elderly patients, for patients with moderate to marked renal impairment (creatinine clearance <40 ml/min) or with moderate to marked hepatic dysfunction. For patients with possible depletion of intravascular volume (e.g. patients treated with diuretics, particularly those with impaired renal function), Olmesartan should be initiated under close medical supervision and consideration should be given to use of a lower starting dose. Olmesartan may be administered with or without food.

Interaction

With medicine: No significant drug interactions were reported in which Olmesartan was co-administered.
With food & others: Food does not affect the bioavailability of Olmesartan.

Contraindications

Olmesartan is contraindicated in patients who are hypersensitive to any component of this product.

Side Effects

Common: The most common side effects include Back pain, bronchitis, creatine phosphokinase increased, diarrhea, headache, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, and sinusitis.

Rare: Chest pain, peripheral edema, arthritis.

Pregnancy & Lactation

Pregnancy: When pregnancy is detected, discontinue this product as soon as possible. When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus.

Nursing Mothers: It is not known whether Olmesartan is excreted in human milk, but Olmesartan is secreted at low concentration in the milk of lactating rats. Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals treated with olmesartan medoxomil. In patients whose renal function may depend upon the activity of the renin-angiotensin-aldosterone system (e.g. patients with severe congestive heart failure), treatment with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death. Similar results may be anticipated in patients treated with olmesartan medoxomil.

Overdose Effects

Symptoms: There is no experience of overdose with Olmesartan. The most likely effects of olmesartan medoxomil overdosage are hypotension and tachycardia; bradycardia could be encountered if parasympathetic (vagal) stimulation occurred.

Treatment: If intake is recent, gastric lavage or induction of emesis may be considered. Clinically significant hypotension due to an overdose of Olmesartan requires the active support of the cardiovascular system, including close monitoring of heart and lung function, the elevation of the extremities, and attention to circulating fluid volume and urine output.

Storage Conditions

Store in cool & dry place below 30ºC, protect from light & moisture. Keep out of the reach of children.

Alternative brands of Olmesartan Medoxomil

Other brands with the same generic name, cheapest first.

See all 29 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.